Recreating the biological steps of viral infection on a cell-free bioelectronic platform to profile viral variants of concern.

Viral mutations frequently outpace technologies used to detect harmful variants. Given the continual emergence of SARS-CoV-2 variants, platforms that can identify the presence of a virus and its propensity for infection are needed. Our electronic biomembrane sensing platform recreates distinct SARS-CoV-2 host cell entry pathways and reports the progression of entry as electrical signals. We focus on two necessary entry processes mediated by the viral Spike protein: virus binding and membrane fusion, which can be distinguished electrically. We find that closely related variants of concern exhibit distinct fusion signatures that correlate with trends in cell-based infectivity assays, allowing us to report quantitative differences in their fusion characteristics and hence their infectivity potentials. We use SARS-CoV-2 as our prototype, but we anticipate that this platform can extend to other enveloped viruses and cell lines to quantifiably assess virus entry. Screening platforms for rapid detection of infectious viruses are needed for diagnostic and therapeutic development. Here, authors present a bioelectronic platform that detects the entry processes of infectious viruses within minutes and differentiates the relative fusogenicities of viral variants. [ABSTRACT FROM AUTHOR]